Your session is about to expire
← Back to Search
PRF-110 for Postoperative Pain in Bunions
Phase 3
Waitlist Available
Research Sponsored by PainReform LTD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 72 hours
Awards & highlights
Pivotal Trial
Summary
This trial tests PRF-110, an oily solution with ropivacaine, for pain relief in patients having bunion surgery. It works by slowly releasing the pain medicine over a few days, reducing the need for other painkillers.
Who is the study for?
Adults over 18 scheduled for bunion surgery who can consent and communicate with the study team. Women must use effective birth control or be non-fertile. Participants need a BMI ≤35, no drug/alcohol abuse, not on certain medications like opiates or NSAIDs recently, and have good organ function.
What is being tested?
The trial is testing PRF-110, an extended-release ropivacaine solution for pain relief after bunion surgery. It's compared to a placebo and another painkiller in a double-blind setup where neither doctors nor patients know who gets which treatment.
What are the potential side effects?
Ropivacaine may cause side effects such as low blood pressure, nausea, vomiting, dizziness, numbness around the mouth, tingling sensations or ringing in the ears. Severe reactions are rare but could include seizures or heart problems.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 72 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~72 hours
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Measurement of patients pain levels as an indication for the analgesic efficacy of PRF-110
Secondary study objectives
Comparison of opiate use to ropivacaine HCL injection
Comparison of opiate use to saline placebo
Measurement of patients pain levels of PRF-110 as compared to ropivacaine hydrochloride
+1 moreAwards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: PRF-110Experimental Treatment1 Intervention
PRF-110 3.6% ropivacaine, to be applied into the surgical wound
Group II: RopivacaineActive Control1 Intervention
Ropivacaine Hydrochloride 0.5%, up to 10 mL, to be applied into the surgical site
Group III: Saline .9%Placebo Group1 Intervention
Saline .9%, to b be applied into the surgical wound
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ropivacaine
2017
Completed Phase 4
~1960
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for bunions include conservative methods, pharmacological treatments, and surgical interventions. Local anesthetics like ropivacaine, as studied in PRF-110, work by blocking nerve signals in the area where they are applied, providing significant pain relief post-surgery.
This is crucial for bunion patients as it helps manage post-operative pain effectively, allowing for a smoother recovery and improved mobility. By reducing pain, these treatments can enhance the overall quality of life and facilitate faster rehabilitation.
Metatarsal head resection in the deformed, symptomatic rheumatic foot. A comparison of two methods.The dose effect of continuous passive motion in postoperative rehabilitation of the first metatarsophalangeal joint.Perioperative pain management and chronic postsurgical pain after elective foot and ankle surgery: a scoping review.
Metatarsal head resection in the deformed, symptomatic rheumatic foot. A comparison of two methods.The dose effect of continuous passive motion in postoperative rehabilitation of the first metatarsophalangeal joint.Perioperative pain management and chronic postsurgical pain after elective foot and ankle surgery: a scoping review.
Find a Location
Who is running the clinical trial?
PainReform LTDLead Sponsor
3 Previous Clinical Trials
45 Total Patients Enrolled
Lotus Clinical Research, LLCOTHER
14 Previous Clinical Trials
1,353 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: PRF-110
- Group 2: Saline .9%
- Group 3: Ropivacaine
Awards:
This trial has 1 awards, including:- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.